Telesis Bio Q3 EPS $(0.42) Beats $(0.48) Estimate, Sales $6.68M Beat $5.30M Estimate
Telesis Bio Q3 EPS $(0.42) Beats $(0.48) Estimate, Sales $6.68M Beat $5.30M Estimate
Telesis Bio第三季度每股收益0.42美元超過預期0.48美元，銷售額668萬美元超過預期530萬美元
Telesis Bio (NASDAQ:DNAY) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.48) by 12.5 percent. This is a 23.53 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $6.68 million which beat the analyst consensus estimate of $5.30 million by 26.04 percent. This is a 139.77 percent increase over sales of $2.79 million the same period last year.
納斯達克公佈季度每股虧損0.42美元，比分析師一致預期的0.48美元高出12.5個百分點。這比去年同期每股虧損0.34美元減少了23.53%。該公司公佈的季度銷售額為668萬美元，比分析師普遍預期的530萬美元高出26.04%。這比去年同期279萬美元的銷售額增長了139.77個百分點。